Peter Lebowitz

Peter Lebowitz leads Third Arc Bio, which is developing multifunctional antibodies to modulate T cells in solid tumors and inflammatory diseases. Previously, he led oncology research and development at Johnson & Johnson and held oncology development leadership roles at GSK. He earned an MD and PhD from the University of Pennsylvania.

Career